Bethlehem-based Saladax acquires patent portfolio from Janssen Pharmaceutica

Bethlehem-based Saladax acquires patent portfolio from Janssen Pharmaceutica

BETHLEHEM, Pa. – Bethehem-based Saladax Biomedical Inc. has acquired a patent portfolio from Janssen Pharmaceutica NV. Saladax didn’t disclose phrases of the settlement to accumulate mental property from Janssen, which is a part of Johnson & Johnson. The transaction consists of 17 patent households and, together with Saladax’s current mental property, covers the main antipsychotic…